Appendix 4: summary of findings tables Question: Does the dietary intake of arabinoxylan (AX) reduce peak postprandial glucose concentration? Source: FSANZ systematic review of evidence. Mean Quality Participant difference (degree of Quality assessment of body of evidence numbers mmol/L certainty in [95% CI] relationship) Number Risk of of Design Inconsistency Indirectness Imprecision Considerations Parallel bias studies Changes in postprandial glucose concentration are related to consuming AX-rich fibre -0.56 5 RCT Low None None Serious None 0 70 Moderate Changes in postprandial blood glucose concentration are related to consuming pure AX Not Not Not Not Not Not 0 NA Not applicable 0 0 assessable applicable applicable applicable assessable assessable
Appendix 4: summary of findings tables Question: Does the dietary intake of arabinoxylan (AX) reduce peak postprandial glucose concentration? Source: FSANZ systematic review of evidence. Quality assessment of body of evidence Participant numbers Mean difference mmol/L [95% CI] Quality (degree of certainty in relationship) Number of studies Design Risk of bias Inconsistency Indirectness Imprecision Considerations Parallel Changes in postprandial glucose concentration are related to consuming AX-rich fibre 5 RCT Low None None Serious None 0 70 -0.56 Moderate Changes in postprandial blood glucose concentration are related to consuming pure AX 0 NA Not assessable Not applicable Not applicable Not applicable Not applicable 0 0 Not assessable Not assessable
AX%20glucose%20review.docx